Doping in sports and the fight against it has gained increasing attention in recent years. The pharmacological basis for a possible performance enhancement in competitive sport through the administration of prohibited substances and methods as well as the analytical disclosure of such practices are comprehensively covered in 21 contributions by outstanding and distinctive authors.

Doping, Performance-Enhancing Drugs, and Hormones in Sport: Mechanisms of Action and Methods of Detection examines the biochemistry and bioanalytical aspects of performance-enhancing drugs (PEDs) and other questionable procedures used by athletes to enhance performance. The book informs the specialist of emerging knowledge and techniques and allows the non-specialist to grasp the underlying science and current practice of the discipline. With clear and compelling language appropriate for a broad spectrum of readers, this book provides background on prevalence, types of agents, their actual or supposed benefits, and their negative effects on health. The technical aspects of detection are discussed, followed by a discussion of why detection is a problematic and still-evolving science. To facilitate comprehension, each chapter is organized in a uniform way with six sections: (1) standard medical uses, (2) why the drugs are used by athletes, (3) biological mechanism of action, (4) what research says about efficacy in improving performance, (5) major health side effects from use and abuse in sport, and 6) concluding key points. - Presents the scientific concepts of how performance enhancers work, how they are used, and how they are detected and masked from detection - Features language that is neither simplistic to scientists nor too sophisticated for a large, diverse global audience - Provides a short "close-up in each chapter to illustrate key topics that engage, entertain, and create a novel synthesis of thought

This book brings together an interdisciplinary group of experts in bioethics, sports, law, and philosophy to examine the need for regulating such athletic performance-enhancing technologies as steroids and gene doping. The use of performance-improving drugs in sports dates back to the early Olympians, who took an herbal tonic before competitions to augment athletic prowess. But the permissibility of doing so came into question only in the twentieth century as the popularity of anabolic steroid use and blood doping among athletes grew. Sports officials and others—aided by the development of technologies to test participants for proscribed substances—became concerned over the physical safety of athletes and competitive fairness in sporting events. In exploring the culture, ethics, and policy issues surrounding doping in competitive athletics, the contributors to this volume detail the history and current state of drug use in sports, analyze the distinctions between acceptable and unacceptable usages, evaluate the ethical arguments for and against permitting athletes to avail themselves of new means of improving athleticism, and discuss possible future doping technologies and the issues that they are likely to raise. They explain how and why some athletes resort to doping and assess what the fair opportunity principle means in theory and practice and how it relates to the concept of an equal opportunity to perform. This frank discussion of doping in sports includes accounts by former elite athletes and offers an illuminating exchange over the meaning and value of natural talents and genetic hierarchies and the essence of fair competition.

This BMA report discusses the current situation regarding performance enhancing drugs as well as the effects of prescribed medication on sports people's performance. Written with expert advice, and rigorously reviewed by specialists, the report addresses the physician's role and responsibilities in this highly sensitive area. It will prove an invaluable guide for all doctors who are involved with the well being of sports people.

The work of dope testers is constantly being obstructed by the development of ever harder-to-trace new forms of banned substances. Organisations such as the World Anti-Doping Association and the United States Anti-Doping Agency are pioneering cutting-edge techniques designed to keep competition at the highest level fair and safe, and must ensure that their drug testing laboratories adhere to the highest scientific standards. In Pharmacology, Doping and Sports these techniques and procedures are explained by the anti-doping experts who practice them. Broad-ranging in scope, this book examines the effects of performance-enhancing substances on the athlete’s health; the role of anti-doping procedures as an ethical question, and explains the background to, and the emergence of, the anti-doping movement. The book also offers in-depth analysis of key scientific matters, such as: standard analytical and diagnostic tests for sports doping regulatory standards for laboratory proficiency common performance-enhancing techniques such as anabolic and designer steroids, blood doping, growth hormones, and gene doping carbon-isotope ratio testing. Written by some of the world's leading authorities on the science of sports doping, Pharmacology, Doping and Sports provides an invaluable study of up-to-the-minute anti-doping techniques. This book is essential reading for all sports scientists, coaches, policy-makers, students and athletes interested in the science or ethics of doping in sport.

Anabolic androgenic steroids (AAS) remain the most used/abused drugs in the athlete and recreational gym user. However, there are some new drugs such as human growth hormone and insulin that are being used by athletes in order to gain a competitive advantage. This book presents separate and multi-disciplinary perspectives of anabolic androgenic steroids and other current drugs of use in sport. The perspectives discussed in this book range from those of sports medicine research scientists, a medical practitioner and sports physician, behavioural scientists and molecular physiologists. There are further contributions from experts in the sociology and ethics of sports doping.

Discusses the use of performance-enhancing drugs among high school and Olympic athletes and efforts to ban drug and steroid use in sports from a variety of viewpoints.

Doping is as old as organized sports. From baseball to horse racing, cycling to track and field, drugs have been used to enhance performance for 150 years. For much of that time, doping to do better was expected. It was doping to throw a game that stirred outrage. Today, though, athletes are vilified for using performance-enhancing drugs. Damned as moral deviants who shred the fair-play fabric, dopers are an affront to the athletes who don’t take shortcuts. But this tidy view swindles sports fans. While we may want the world sorted into villains and victims, putting the blame on athletes alone ignores decades of history in which teams, coaches, governments, the media, scientists, sponsors, sports federations, and even spectators have played a role. The truth about doping in sports is messy and shocking because it holds a mirror to our own reluctance to spit in the soupthat is, to tell the truth about the spectacle we crave. In Spitting in the Soup, sports journalist Mark Johnson explores how the deals made behind closed doors keep drugs in sports. Johnson unwinds the doping culture from the early days, when pills meant progress, and uncovers the complex relationships that underlie elite sports culturethe essence of which is not to play fair but to push the boundaries of human performance. It’s easy to assume that drugs in sports have always been frowned upon, but that’s not true. Drugs in sports are old. It’s banning drugs in sports that is new. Spitting in the Soup offers a bitingly honest, clear-eyed look at why that’s so, and what it will take to kick pills out of the locker room once and for all.

This book brings together the best thinking from both sides of the Atlantic to explore the issues surrounding soaring health care costs. It employs disciplinary perspectives from economics, ethics, philosophy, psychology, clinical practice, and epidemiology to explore various ways that value for patients have and can be determined. A major section of the book discusses problems that can reduce the value to patients of medical care. The volume is must read for practitioners, policy makers, and researchers who want to find in one place the state-of-the-art thinking and future directions of valuing medical care from the patient’s perspective.

From turn-of-the-century horseracing to the monolithic anti-doping attitudes now supported by sporting organizations, the development of anti-doping ideology has spread throughout modern sport. Yet heretofore few historians have explored the many ways that international sport has responded to doping. This book seeks to fill that gap by examining different aspects of sport’s global efforts to respond to athletes doping. By incorporating cultural, political, and feminist histories that examine international responses to doping, this special issue aims to better articulate the narrative of doping. The work starts with the first mention of doping in any sport. It examines not only the first efforts to ban doping but also the athletes who sought performance enhancers. Focusing on specific framing events, authors in this issue examine how history of doping and how it has indelibly marked the sporting landscape. The result is a work with both breadth and focus. From stories of Japanese swimmers to Italian runners to American jockeys, the work spans the range of doping history. At the same time, the authors remain focused around one single issue: the history of doping in sport. This bookw as published as a special issue of the International Journal of the History of Sport.